In-Vitro Diagnostics Global Market Briefing 2019
Report Highlights
Including: Clinical Chemistry Diagnostics Devices And Equipment; Hematology Diagnostic Devices And Equipment; Hemostasis Dagnostic Devices And Equipment; Immunochemistry Diagnostic Devices And Equipment; Immunohematology Diagnostic Devices And Equipment; Microbiology Diagnostic Devices And Equipment; Molecular Diagnostics Devices And Equipment; Point-of-Care Diagnostics Devices And Equipment
Covering: Thermo Fisher Scientific; Siemens Healthineers; Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Cardinal Health, Inc.
Research Methodology
The Business Research Company’s reports are based on the methodology below.
Data
Our datasets are created using a wide range of proprietary and public sources including leading government bodies, associations, trade journals, market intelligence reports and trade magazines. Data is modelled based on hard data, extrapolation, regression analysis based on known macro data inputs, interpolation betweenhard figures, comparisons with other geographies and markets, price estimations, and qualitative inputs. Data is triangulated within our unique market data model covering an exhaustive list of 200+ markets across 12
countries and 5 regions. Comparable data is used for sanity check and trend analysis. For example our global market value data is compared to unit sales and price data for the relevant market as well as relevant macroeconomic datasets in order to establish validity.
Market Numbers –
Market value is defined as the revenues earned by organizations for products and services within the specified market. The break down by geography is revenue generated within the specific industry by organizations in the specified geography, irrespective of where they are produced.
Competitor Market Share Data
The competitor market share data is intended to represent the companies that gain the most revenues from the given market and the percentage share of the market that they hold. If a company derives most of its revenues from the market, its revenues are given in full. If a large part of the company's revenues come from other markets, only the division of the company which operates in this market is included. Where accurate information is not available on the revenues a company generates from the market its market share is not included, however a profile of the company may still be included if it is a significant competitor in the market.
Analysis
Analysis is drawn from our Consultants’ wide range of industry and research experience as well as public and proprietary sources. Consultants are trained in research techniques and ethics by the Market Research Society.
Verification Through Expert Interviews
Every year The Business Research Company carries out thousands of interviews with senior executives and industry experts across hundreds of markets. Through these interviews we develop our internal understanding of markets and geographies and cross reference our understanding of global markets with expert feedback utilizing ‘Delphic’ research methodologies.
Referencing
The Business Research Company prides itself on the quality and validity of its data and analysis. Our unique ‘end noted’ referencing approach allows the user to trace our market numbers and analysis back to the specific data sources they were derived from.
Note on Currency Conversions –
All currency conversions are done on the basis of 2017 exchange rates.
North America was the largest region in the in-vitro diagnostics market worth $21.8 billion in 2018, accounting for 41.1% of the global in-vitro diagnostics market, followed by Asia Pacific at 25.7% and Western Europe at 19.1% respectively.
In-Vitro Diagnostics Global Market Briefing 2019 provides strategists, marketers and senior management with the critical information they need to assess the global in-vitro diagnostics sector.
Reasons to Purchase
- Fully updated for 2019.
- Identify growth segments and opportunities.
- Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
- Develop strategies based on likely future developments.
- Gain a global perspective on the development of the market.
Description
In-Vitro Diagnostics Global Market Briefing from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.
The market characteristics section of the report defines and explains the market.
The market size section gives the in-vitro diagnostics market revenues, covering both the historic growth of the market and forecasting the future.
Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.
The trends and strategies section highlights the likely future developments in the in-vitro diagnostics market and suggests approaches.
Scope
Markets Covered: Clinical Chemistry Diagnostics Devices And Equipment; Hematology Diagnostic Devices And Equipment; Hemostasis Dagnostic Devices And Equipment; Immunochemistry Diagnostic Devices And Equipment; Immunohematology Diagnostic Devices And Equipment; Microbiology Diagnostic Devices And Equipment; Molecular Diagnostics Devices And Equipment; Point-of-Care Diagnostics Devices And Equipment
Companies Mentioned: Thermo Fisher Scientific; Siemens Healthineers; Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Cardinal Health, Inc.
Geographic scope: Asia Pacific, North America, Western Europe, Eastern Europe, South America, Middle East, Africa
Countries: Australia, China, Hong Kong, India, Indonesia, Japan, South Korea, Malaysia, New Zealand, Philippines, Singapore, Thailand, Vietnam, Canada, USA, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, the UK, Czech Republic, Poland, Romania, Russia, Israel, Saudi Arabia, Turkey, UAE, Egypt, Nigeria, South Africa
Time series: Five years historic and forecast
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, market share of competitors, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Table 1 : Global In-Vitro Diagnostics Market, Historic Market Size, 2014-2018
- Table 2 : Global In-Vitro Diagnostics Market, Forecast Market Size, 2018-2022
- Table 3 : Global In-Vitro Diagnostics Market, Split By Segment, 2018
- Table 4 : Global In-Vitro Diagnostics Market, Historic And Forecast, Split By Segment, 2014-2022
- Table 5 : Global In-Vitro Diagnostics Market, Split By Region, 2018
- Table 6 : Global In-Vitro Diagnostics Market, Historic And Forecast Growth Rate, Split By Region, 2014-2022
- Figure 1 : Global In-Vitro Diagnostics Market, Historic Market Size, 2014-2018
- Figure 2 : Global In-Vitro Diagnostics Market, Forecast Market Size, 2018-2022
- Figure 3 : Global In-Vitro Diagnostics Market, Split By Segment, 2018
- Figure 4 : Global In-Vitro Diagnostics Market, Historic And Forecast, Split By Segment, 2014-2022
- Figure 5 : Global In-Vitro Diagnostics Market, Split By Region, 2018
- Figure 6 : Global In-Vitro Diagnostics Market, Historic And Forecast Growth Rate, Split By Region, 2014-2022
The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.